Inappropriate use of progression-free survival in cancer drug approvals.
作者信息
Naci Huseyin, Davis Courtney
机构信息
Department of Health Policy, London School of Economics and Political Science, London, UK
Department of Global Health and Social Medicine, King's College London, London, UK.
出版信息
BMJ. 2020 Mar 10;368:m770. doi: 10.1136/bmj.m770.
DOI:10.1136/bmj.m770
PMID:32156802
Abstract
摘要
Zotero 插件